Oxford Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,448
Closed -$679K 597
2025
Q2
$679K Buy
+4,448
New +$684K 0.22% 126
2025
Q1
Sell
-12,219
Closed -$1.77M 598
2024
Q4
$1.77M Buy
12,219
+8,804
+258% +$1.36M 0.79% 16
2024
Q3
$553K Buy
+3,415
New +$544K 0.46% 60
2020
Q1
Sell
-81,253
Closed -$11.9M 761
2019
Q4
$11.9M Buy
81,253
+6,946
+9% +$942K 0.33% 43
2019
Q3
$9.61M Sell
74,307
-43,348
-37% -$5.71M 0.23% 97
2019
Q2
$16.4M Buy
117,655
+19,509
+20% +$2.7M 0.35% 30
2019
Q1
$13.7M Buy
98,146
+62,589
+176% +$8.38M 0.3% 44
2018
Q4
$4.59M Sell
35,557
-26,336
-43% -$3.67M 0.12% 190
2018
Q3
$8.55M Buy
61,893
+55,297
+838% +$7.35M 0.18% 119
2018
Q2
$805K Buy
+6,596
New +$823K 0.02% 1138
2018
Q1
Sell
-51,428
Closed -$7.23M 1757
2017
Q4
$7.23M Buy
51,428
+23,997
+87% +$3.34M 0.16% 138
2017
Q3
$3.56M Buy
27,431
+22,030
+408% +$2.92M 0.07% 338
2017
Q2
$714K Buy
+5,401
New +$689K 0.01% 1002

Other funds holding JNJ

Oxford Asset Management's JNJ Position: Q3 2025 in Review

Oxford Asset Management sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 4,448 shares — an estimated $679K sold.

Oxford Asset Management first reported a position in JNJ in Q2 2017 and held it in 13 quarters. The position peaked at $16.4M in Q2 2019. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Oxford Asset Management reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Oxford Asset Management sold 4,448 Johnson & Johnson shares in Q3 2025, an estimated $679K.
  • Oxford Asset Management first reported a position in Johnson & Johnson in Q2 2017 and held it in 13 quarters.
  • Oxford Asset Management's Johnson & Johnson position peaked at $16.4M in Q2 2019.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.